Michael A Lloyd

US Patent:

20130182929, Jul 18, 2013

Filed:

Jan 16, 2013

Appl. No.:

13/742648

Inventors:

Emory University - Atlanta GA, US
Georgia Tech Research Corporation - Atlanta GA, US
Michael S. Lloyd - Avondale Estates GA, US
Angel R. Leon - Atlanta GA, US

Assignee:

GEORGIA TECH RESEARCH CORPORATION - Atlanta GA
EMORY UNIVERSITY - Atlanta GA

International Classification:

G06T 11/00

US Classification:

382131, 382128

Abstract:

Systems, methods and computer-readable storage mediums relate to generating an image that includes functional, anatomical, and physiological images. The generated image may be an integrated image based on the functional image on which the anatomical and physiological images are mapped. The generated image may indicate more than one location of optimal lead placement. The generated image may be useful in pre-planning cardiac intervention procedures.

US Patent:

20210214291, Jul 15, 2021

Filed:

Jan 24, 2020

Appl. No.:

16/752139

Inventors:

Michael Lloyd - Decatur GA, US

International Classification:

C07C 5/25
B01J 19/12

Abstract:

The use of lycopene has been demonstrated to be effective in decreasing risk factors associated with cardiovascular disease, skin cancer and prostate cancer in mammals. Lycopene is difficult to solubilize in its native trans-lycopene form. Cis-lycopene, formed by applying thermal energy generated by excitation of polar molecules through microwave-assisted processing, appears in several isomeric forms. The cis isomers are effective in improving lycopene micellularization, bioaccessibility and mammalian absorption. The cis isomers are effective in improving vascular circulation of lycopene by way transport vesicle low density lipo-protein (LDL). Lycopene-based ingredients, end products, functional foods, medical foods and nutraceuticals, containing isomerized cis-lycopene can be used in place of ingredients with more naturally abundant trans-lycopene as phytonutrient, micronutrient and antioxidant delivery vehicles through dietary consumption to improve the outcomes of a variety of conditions, including hypertension, cardiovascular disease, skin cancer, prostate cancer, macular degeneration and related proinflammatory conditions.

US Patent:

20160235996, Aug 18, 2016

Filed:

Feb 17, 2016

Appl. No.:

15/046260

Inventors:

Michael Shane Lloyd - Atlanta GA, US
Jonathan Jason Langberg - Atlanta GA, US

International Classification:

A61N 1/39

Abstract:

Technologies are disclosed herein for a low impedance detection system. The detection system includes an electrical insulation and an impedance measurement device. The impedance measurement device can be used to test the impedance of the system when the barrier is placed between the user of the barrier and a source of electrical power. In a defibrillation system, a rescuer can place the barrier over the patient. An electrical power source can deliver electrical shocks to the patient. The impedance measurement device can monitor impedances of the system across various frequencies to detect electrical conditions that might be harmful to the rescuer.